99 related articles for article (PubMed ID: 11194892)
1. Targeted delivery of DNA encoding herpes simplex virus type-1 glycoprotein D enhances the cellular response to primary viral challenge.
Rogers JV; Bigley NJ; Chiou HC; Hull BE
Arch Dermatol Res; 2000 Nov; 292(11):542-9. PubMed ID: 11194892
[TBL] [Abstract][Full Text] [Related]
2. Murine response to DNA encoding herpes simplex virus type-1 glycoprotein D targeted to the liver.
Rogers JV; Hull BE; Fink PS; Chiou HC; Bigley NJ
Vaccine; 2000 Feb; 18(15):1522-30. PubMed ID: 10618550
[TBL] [Abstract][Full Text] [Related]
3. A novel immunization method to induce cytotoxic T-lymphocyte responses (CTL) against plasmid-encoded herpes simplex virus type-1 glycoprotein D.
Cruz PE; Khalil PL; Dryden TD; Chiou HC; Fink PS; Berberich SJ; Bigley NJ
Vaccine; 1999 Mar; 17(9-10):1091-9. PubMed ID: 10195619
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of a DNA vaccine encoding herpes simplex virus type 1 (HSV-1) glycoprotein D in decreasing ocular disease severity following corneal HSV-1 challenge.
Frye TD; Chiou HC; Hull BE; Bigley NJ
Arch Virol; 2002 Sep; 147(9):1747-59. PubMed ID: 12209314
[TBL] [Abstract][Full Text] [Related]
5. Preventive effect of local plasmid DNA vaccine encoding gD or gD-IL-2 on herpetic keratitis.
Inoue T; Inoue Y; Nakamura T; Yoshida A; Takahashi K; Inoue Y; Shimomura Y; Tano Y; Fujisawa Y; Aono A; Hayashi K
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4209-15. PubMed ID: 11095617
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.
BenMohamed L; Bertrand G; McNamara CD; Gras-Masse H; Hammer J; Wechsler SL; Nesburn AB
J Virol; 2003 Sep; 77(17):9463-73. PubMed ID: 12915561
[TBL] [Abstract][Full Text] [Related]
8. Immunization with different viral antigens alters the pattern of T cell exhaustion and latency in herpes simplex virus type 1-infected mice.
Allen SJ; Mott KR; Zandian M; Ghiasi H
J Virol; 2010 Dec; 84(23):12315-24. PubMed ID: 20861248
[TBL] [Abstract][Full Text] [Related]
9. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens.
Karem KL; Bowen J; Kuklin N; Rouse BT
J Gen Virol; 1997 Feb; 78 ( Pt 2)():427-34. PubMed ID: 9018066
[TBL] [Abstract][Full Text] [Related]
10. Immunological properties of a DNA plasmid encoding a chimeric protein of herpes simplex virus type 2 glycoprotein B and glycoprotein D.
Domingo C; Gadea I; Pardeiro M; Castilla C; Fernández S; Fernández-Clua MA; De la Cruz Troca JJ; Punzón C; Soriano F; Fresno M; Tabarés E
Vaccine; 2003 Sep; 21(25-26):3565-74. PubMed ID: 12922084
[TBL] [Abstract][Full Text] [Related]
11. Immunization with DNA vaccine expressing herpes simplex virus type 1 gD and IL-21 protects against mouse herpes keratitis.
Hu K; He X; Yu F; Yuan X; Hu W; Liu C; Zhao F; Dou J
Immunol Invest; 2011; 40(3):265-78. PubMed ID: 21204603
[TBL] [Abstract][Full Text] [Related]
12. The effect of immunization with herpes simplex virus glycoprotein D fused with interleukin-2 against murine herpetic keratitis.
Inoue T; Inoue Y; Nakamura T; Yoshida A; Inoue Y; Tano Y; Shimomura Y; Fujisawa Y; Aono A; Hayashi K
Jpn J Ophthalmol; 2002; 46(4):370-76. PubMed ID: 12225814
[TBL] [Abstract][Full Text] [Related]
13. Coexpression of interleukin-2 enhances the immunization effect of a DNA vaccine expressing herpes simplex 1 glycoprotein D.
Li WR; Niu B; Wang JW; Feng ZJ; Wang DX
Acta Virol; 2006; 50(4):251-6. PubMed ID: 17177610
[TBL] [Abstract][Full Text] [Related]
14. Antibody response and protective capacity of plasmid vaccines expressing three different herpes simplex virus glycoproteins.
Nass PH; Elkins KL; Weir JP
J Infect Dis; 1998 Sep; 178(3):611-7. PubMed ID: 9728527
[TBL] [Abstract][Full Text] [Related]
15. Enhanced resistance to nuclease degradation of nucleic acids complexed to asialoglycoprotein-polylysine carriers.
Chiou HC; Tangco MV; Levine SM; Robertson D; Kormis K; Wu CH; Wu GY
Nucleic Acids Res; 1994 Dec; 22(24):5439-46. PubMed ID: 7816636
[TBL] [Abstract][Full Text] [Related]
16. Receptor-mediated gene delivery and expression in vivo.
Wu GY; Wu CH
J Biol Chem; 1988 Oct; 263(29):14621-4. PubMed ID: 3049582
[TBL] [Abstract][Full Text] [Related]
17. Targeted delivery of mitochondria to the liver in rats.
Liu X; Khouri-Farah N; Wu CH; Wu GY
J Gastroenterol Hepatol; 2020 Dec; 35(12):2241-2247. PubMed ID: 32386240
[TBL] [Abstract][Full Text] [Related]
18. Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in Mice.
Liu SA; Stanfield BA; Chouljenko VN; Naidu S; Langohr I; Del Piero F; Ferracone J; Roy AA; Kousoulas KG
J Virol; 2017 Jun; 91(12):. PubMed ID: 28404844
[TBL] [Abstract][Full Text] [Related]
19. Co-immunization with plasmids coding the full length and a soluble form of glycoprotein D of HSV-2 induces protective cellular and humoral immune response in mice.
Fló J
Vaccine; 2003 Mar; 21(11-12):1239-45. PubMed ID: 12559804
[TBL] [Abstract][Full Text] [Related]
20. Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.
Bettahi I; Nesburn AB; Yoon S; Zhang X; Mohebbi A; Sue V; Vanderberg A; Wechsler SL; BenMohamed L
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4643-53. PubMed ID: 17898288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]